Cargando…
En-route to the ‘elimination’ of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal
BACKGROUND: Anti-malarial resistance is, and continues to be a significant challenge in the fight against malaria and a threat to achieving malaria elimination. In Zambia, chloroquine (CQ), a safe, affordable and well-tolerated drug, was removed from use in 2003 due to high levels of resistance evid...
Autores principales: | Sitali, Lungowe, Mwenda, Mulenga C., Miller, John M., Bridges, Daniel J., Hawela, Moonga B., Chizema-Kawesha, Elizabeth, Chipeta, James, Lindtjørn, Bernt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889585/ https://www.ncbi.nlm.nih.gov/pubmed/31796087 http://dx.doi.org/10.1186/s12936-019-3031-4 |
Ejemplares similares
-
Distribution of Plasmodium species and assessment of performance of diagnostic tools used during a malaria survey in Southern and Western Provinces of Zambia
por: Sitali, Lungowe, et al.
Publicado: (2019) -
Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia
por: Mulenga, Mwenda C., et al.
Publicado: (2021) -
Data on selected antimalarial drug resistance markers in Zambia
por: Sitali, Lungowe, et al.
Publicado: (2020) -
Patterns of mixed Plasmodium species infections among children six years and under in selected malaria hyper-endemic communities of Zambia: population-based survey observations
por: Sitali, Lungowe, et al.
Publicado: (2015) -
Implications of the MDA Trial in Southern Province, Zambia, for Malaria Control and Elimination
por: Steketee, Richard W., et al.
Publicado: (2020)